ConductScience.org, home

Paper39474609

Willingness to pay and price elasticity of demand for long-acting injectable cabotegravir among men who have sex with men in Guangxi, China.

Chen S and 11 others. Front Pharmacol, 2024. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Willingness to pay and price elasticity of demand for long-acting injectable cabotegravir among men who have sex with men in Guangxi, China. Papers, record 39474609. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39474609

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Willingness to pay and price elasticity of demand for long-acting injectable cabotegravir among men who have sex with men in Guangxi, China.
PubMed
Journal
Front Pharmacol
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.13, provisional
iCite
Revised in PubMed
2024-10-30
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen SShiwen
2Ruan YYuhua
3Liu LLu
4Pei HHengyan
5Jiang YYu
6Huang TTengda
7Wei YYuxia
8Qin LLitai
9Dai XXuebin
10Liu YYu
11Liu JJunhui
12Xie YYihong

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131340482Willingness to Use and Adhere to HIV Pre-Exposure Prophylaxis (PrEP) among Men Who Have Sex with Men (MSM) in China.Int J Environ Res Public Health2019https://conductscience.org/library/papers/31340482PubMed
234142274Preferences for Current and Future PrEP Modalities Among PrEP-Experienced Gay and Bisexual Men in Australia.AIDS Behav2022https://conductscience.org/library/papers/34142274PubMed
328176168A Global Estimate of the Acceptability of Pre-exposure Prophylaxis for HIV Among Men Who have Sex with Men: A Systematic Review and Meta-analysis.AIDS Behav2018https://conductscience.org/library/papers/28176168PubMed
436631515Awareness and use of HIV pre-exposure prophylaxis and factors associated with awareness among MSM in Beijing, China.Sci Rep2023https://conductscience.org/library/papers/36631515PubMed
533611697Slow Uptake of PrEP: Behavioral Predictors and the Influence of Price on PrEP Uptake Among MSM with a High Interest in PrEP.AIDS Behav2021https://conductscience.org/library/papers/33611697PubMed
632178657Low willingness to pay for pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) in China.BMC Public Health2020https://conductscience.org/library/papers/32178657PubMed
737139146Analysis of Knowledge Level and Use of Antiretroviral Pre-Exposure and Post-Exposure Prophylaxis Among MSM - China, 2019-2022.China CDC Wkly2023https://conductscience.org/library/papers/37139146PubMed
829290075Expanding the Menu of HIV Prevention Options: A Qualitative Study of Experiences with Long-Acting Injectable Cabotegravir as PrEP in the Context of a Phase II Trial in the United States.AIDS Behav2018https://conductscience.org/library/papers/29290075PubMed
931842772Prepared for PrEP: preferences for HIV pre-exposure prophylaxis among Chinese men who have sex with men in an online national survey.BMC Infect Dis2019https://conductscience.org/library/papers/31842772PubMed
1030870322Monitoring HIV Preexposure Prophylaxis Use Among Men Who Have Sex With Men in Washington State: Findings From an Internet-Based Survey.Sex Transm Dis2019https://conductscience.org/library/papers/30870322PubMed
1131298662Changes in HIV Preexposure Prophylaxis Awareness and Use Among Men Who Have Sex with Men - 20 Urban Areas, 2014 and 2017.MMWR Morb Mortal Wkly Rep2019https://conductscience.org/library/papers/31298662PubMed
1235148029
Engagement in the pre-exposure prophylaxis (PrEP) cascade among a respondent-driven sample of sexually active men who have sex with men and transgender women during early PrEP implementation in Zimbabwe.
J Int AIDS Soc2022https://conductscience.org/library/papers/35148029PubMed
1339095714
Potential healthcare resource use and associated costs of every 2 month injectable cabotegravir plus rilpivirine long-acting regimen implementation in the Spanish National Healthcare System compared to daily oral HIV treatments.
BMC Infect Dis2024https://conductscience.org/library/papers/39095714PubMed
1436991027Exploring preferences and decision-making about long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young sexual minority men 17-24 years old.Sci Rep2023https://conductscience.org/library/papers/36991027PubMed
1527459164Willingness to Self-Pay for Pre-exposure Prophylaxis in Men Who Have Sex With Men: A National Online Survey in Taiwan.AIDS Educ Prev2016https://conductscience.org/library/papers/27459164PubMed
1633468089Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in Germany.BMC Public Health2021https://conductscience.org/library/papers/33468089PubMed
1728707025Interest in Long-Acting Injectable PrEP in a Cohort of Men Who have Sex with Men in China.AIDS Behav2018https://conductscience.org/library/papers/28707025PubMed
1835255193Increasing awareness of HIV pre-exposure prophylaxis (PrEP) and willingness to use HIV PrEP among men who have sex with men: a systematic review and meta-analysis of global data.J Int AIDS Soc2022https://conductscience.org/library/papers/35255193PubMed
1936632416Cabotegravir-Global Access to Long-Acting Pre-exposure Prophylaxis for HIV.Open Forum Infect Dis2023https://conductscience.org/library/papers/36632416PubMed
2037823865Daily Oral HIV Pre-exposure Prophylaxis Among Young Men Who Have Sex With Men in the United States: Cost-saving at Generic Drug Price.Clin Infect Dis2024https://conductscience.org/library/papers/37823865PubMed

See all 36 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn PapersSource
42426678Cost-effectiveness of concurrently available oral and long-acting injectable pre-exposure prophylaxis for preventing HIV infections among men who have sex with men in eastern China: A modelling study.BMC Public Health2026https://conductscience.org/library/papers/42426678PubMed
41350365The unseen impact of affordability: copayment sensitivity for long-acting PrEP among MSM in six European Countries, October 2023-April 2024.Sci Rep2025https://conductscience.org/library/papers/41350365PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39474609

GET https://conductscience.org/api/papers/v1/39474609/references?page=2